Please ensure Javascript is enabled for purposes of website accessibility

Why Shares of Chemours Were Down Today

By Lou Whiteman - Mar 31, 2020 at 4:42PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company was dealt a blow in a legal battle against its former parent.

What happened

Shares of Chemours (CC 1.75%) fell more than 8% on Tuesday, and were down more than 10% earlier in the day, after the chemical company's lawsuit against its former parent was dismissed on technical grounds. Chemours has vowed to fight on, but the decision is a setback in its battle to escape some of the environmental liability costs it currently faces.

So what

Chemours, a major supplier of titanium dioxide, was spun out of DuPont (DD 2.37%) in 2015 and held on to a lot of legacy environmental liabilities as part of the separation agreement. Chemours has argued that DuPont's estimates of how much its former subsidiary would be on the hook for were off base and were not prepared in good faith. And so Chemours had gone to court to try to get DuPont to foot more of the bill.

A pile of white pigment powder.

Image source: Getty Images.

Chemours had sought to "uncap" DuPont's liabilities related to PFOA, a chemical once used in nonstick coatings and other products, or require DuPont to pay back a $3.9 billion special dividend paid by Chemours to DuPont in 2015.

Delaware Chancery Court Judge Sam Glasscock III on Monday granted DuPont's request to dismiss the lawsuit, ruling that he had no jurisdiction to hear the case because the separation agreement between the companies states that all disputes arising from the spinoff are subject to binding arbitration.

Chemours said it will appeal the ruling to the Delaware Supreme Court.

Now what

This isn't over, with the appeals process still to play out, but the ruling is a major victory for DuPont and a setback for Chemours.

Even without the litigation worries, Chemours is in a tough spot right now. Its core titanium dioxide product, which is used in sunscreens and as a white pigment in paint, is likely to see light industrial demand in the first half of 2020 (if not beyond) due to the global COVID-19 pandemic slowdown. If we end up in a recession, demand could be weak well into 2021.

Given all that Chemours has to manage right now, it is no wonder investors are heading for the exits.

Lou Whiteman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

The Chemours Company Stock Quote
The Chemours Company
CC
$36.00 (1.75%) $0.62
DuPont de Nemours, Inc. Stock Quote
DuPont de Nemours, Inc.
DD
$62.18 (2.37%) $1.44

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
390%
 
S&P 500 Returns
125%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/11/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.